Analysis of the BRCA1 and BRCA2 genes in search of mutations in women diagnosed with breast cancer at an early age revealed both BRCA1 and BRCA2 mutations, suggesting that genetic testing for mutations in these genes should be offered to women with early onset breast cancer [20]. This evidence concerns the gene BRCA1 and breast carcinoma.